Back to results
US 2025/0145980 A1Published application
ClyRD, A NOVEL CHIMERIC ENDOLYSIN FROM CLOSTRIDIUM PERFRINGENS PHAGES WITH ENHANCED ANTIBACTERIAL ACTIVITY
AssigneeFoundation for Research and Business, Seoul National University of Science and Technology
InventorsMin Suk KONG, Je Na KIM, Su Young SEO
Life of this patent
Estimating the term…
Abstract
A chimeric endolysin ClyRD of the present disclosure has antibacterial activity against bacteria that may cause foodborne diseases. Therefore, the chimeric endolysin ClyRD may be used as a natural controlling agent, a therapeutic agent or a preventive agent in the food industry.
Claims8
A chimeric endolysin protein comprising:
- an enzymatically active domain (EAD);
- a spore-binding domain (SBD);
- and a cell wall-binding domain (CBD).
Dependencies are inferred from the claim text.